@inproceedings{inproceedings, title  = {{A randomized phase II study of AZ2014 versus everolimus in patients with VEGF refractory metastatic clear cell renal cancer (mRCC).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2015}},

 month = {{3}},

 author = {{Powles T and Wheater MJ and Din O and Geldart TR and Boleti E and Stockdale A and Sundar S and Robinson A and Ahmed I and Sarker S-J and Hussain SA et al}},

 doi = {{10.1200/jco.2015.33.7_suppl.409}},

 volume = {{33}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{7_suppl}},

 pages = {{409-409}},

 note = {{Accessed on 2024/12/21}}}